Correction: Herpes Zoster Eye Complications: Rates and Trends (Mayo Clinic Proceedings (2013) 88 (6)(562–570) (S0025619613002309) (10.1016/j.mayocp.2013.03.014));Herpes zoster eye complications: Rates and trends

Mayo Clinic Proceedings

Volumn 88, Issue 6, 2013, Pages 562-570

  Yawn, Barbara P ^a   Wollan, Peter C ^a   St Sauver, Jennifer L ^b   Butterfield, Linda C ^a  

^a OLMSTED MEDICAL CENTER   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; COHORT ANALYSIS; CONJUNCTIVITIS; CORNEA TRANSPLANTATION; DERMATOME; DISEASE SEVERITY; EYE DISEASE; EYE PAIN; FEMALE; HERPES ZOSTER; HUMAN; IMMUNE DEFICIENCY; IRITIS; KERATITIS; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; POPULATION RESEARCH; PTOSIS; RASH; RECURRENT DISEASE; RISK; SUICIDE ATTEMPT; SYMPTOM; UVEITIS; VISUAL IMPAIRMENT; VISUAL SYSTEM EXAMINATION;

EID: 84880230210     PISSN: 00256196     EISSN: 19425546     Source Type: Journal    
DOI: 10.1016/j.mayocp.2017.07.009     Document Type: Erratum

References (62)

1. Yawn BP, Saddier P, Wollan PC, St Sauver JL, Kurland MJ, Sy LS. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc. 2007;82(11):1341-1349.
2. Donahue JG, Choo PW, Manson JE, Platt R. The incidence of herpes zoster. Arch Intern Med. 1995;155(15):1605-1609.
3. Gnann JW Jr, Whitley RJ. Clinical practice. Herpes zoster. N Engl J Med. 2002;347(5):340-346.
4. Gauthier A, Breuer J, Carrington D, Martin M, Remy V. Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom. Epidemiol Infect. 2009;137(1):38-47.
5. Weinberg JM. Herpes zoster: epidemiology, natural history, and common complications. J Am Acad Dermatol. 2007;57(6, suppl): S130-S135.
6. Ragozzino MW, Melton LJ 3rd, Kurland LT, Chu CP, Perry HO. Population-based study of herpes zoster and its sequelae. Medicine (Baltimore). 1982;61(5):310-316.
7. Thomas SL, Hall AJ. What does epidemiology tell us about the risk factors for HZ? Lancet Infect Dis. 2004;4(1):26-33.
8. Yawn BP, Itzler RF, Wollan PC, Pellissier JM, Sy LS, Saddier P. Healthcare utilization and cost burden of herpes zoster in a community population. Mayo Clin Proc. 2009;84(9):787-794.
9. Lydick E, Epstein RS, Himmelberger D, White CJ. Herpes zoster and quality of life: a self-limited disease with severe impact. Neurology. 1995;45(12, suppl 8):S52-S53.
10. Stein AN, Britt H, Harrison C, Conway EC, Cunningham A, Macintyre CR. Herpes zoster burden of illness and health care resource utilization in the Australian population aged 50 years and older. Vaccine. 2009;27(4):520-529.
11. Lang PO, Zarate-Lagunes M, Pautex S. [Herpes zoster and post-herpetic neuralgia in older adults.]. [in French]. Rev Med Suisse. 2008;4(178):2398-2402, 2404.
12. Volpi A, Gatti A, Pica F, Bellino S, Marsella LT, Sabato AF. Clinical and psychosocial correlates of post-herpetic neuralgia. J Med Virol. 2008;80(9):1646-1652.
13. Helgason S, Petursson G, Gudmundsson S, Sigurdsson JA. Prevalence of postherpetic neuralgia after a first episode of herpes zoster: prospective study with long term follow up. BMJ. 2000; 321(7264):794-796.
14. Watson CP. Postherpetic neuralgia: the importance of preventing this intractable end-stage disorder. J Infect Dis. 1998; 178(suppl 1):S91-S94.
15. Wang TJ, Hu CC, Lin HC. Increased risk of anterior uveitis following herpes zoster: a nationwide population-based study. Arch Opthalmol. 2012;130(4):451-455.
16. Severson EF, Baratz KJ, Hodge DO, Burke JP. Herpes zoster ophthalmicus in Olmsted County, Minnesota: have systemic antivirals made a difference? Arch Ophthalmol. 2003;121(3):386-390.
17. Liesegang TJ. Herpes zoster ophthalmicus natural history, risk factors, clinical presentation, and morbidity. Ophthalmology. 2008;115(2, suppl):S3-S12.
18. Adam RS, Vale N, Bona MD, Hasanee K, Farrokhyar F. Triaging herpes zoster ophthalmicus patients in the emergency department: do all patients require referral? Acad Emerg Med. 2010; 17(11):1183-1188.
19. Zaal MJ, Völker-Dieben HJ, D'Amaro J. Visual prognosis in immunocompetent patients with herpes zoster ophthalmicus. Acta Ophthalmol Scand. 2003;81(3):216-220.
20. Ugarte M, Dey S, Jones CA. Ophthalmoplegia secondary to herpes zoster ophthalmicus. BMJ Case Rep. 2010;2010.
21. Ghaznawi N, Virdi A, Dayan A, et al. Herpes zoster ophthalmicus: comparison of disease in patient 60 years and older versus younger than 60 years. Ophthalmology. 2011;118(11):2242-2250.
22. Gupta N, Sachdev R, Sinha R, Titival JS, Tandon R. Herpes zoster ophthalmicus: disease spectrum in young adults. Middle East Afr J Ophthalmol. 2011;18(2):178-182.
23. Puri LR, Shrestha GB, Shah DN, Chaudhary M, Thakur A. Ocular manifestations in herpes zoster ophthalmicus. Nepal J Ophthalmol. 2011;3(2):165-171.
24. McDonald EM, De Kock J, Ram FS. Antivirals for management of herpes zoster including ophthalmicus: a systematic review of high-quality randomized trials. Antiviral Ther. 2012;17(2): 255-264.
25. Kaufman SC. Anterior segment complications of herpes zoster ophthalmicus. Ophthalmology. 2008;115(2, suppl):S24-S32.
26. Nithyanandam S, Dabir S, Stephen J, Joseph M. Eruption severity and characteristics in herpes zoster ophthalmicus: correlation with visual outcome, ocular complications, and postherpetic neuralgia. Int J Dermatol. 2009;48(5):484-487.
27. Kucukardali Y, Solmazgul E, Terekeci H, Oncul O, Turhan V. Herpes zoster ophthalmicus and syndrome of inappropriate antidiuretic hormone secretion. Intern Med. 2008;47(5):463-465.
28. Hahn B, Arnold N, Roth N. Images in emergency medicine. Herpes zoster ophthalmicus with ocular involvement. Ann Emerg Med. 2008;51(2):211, 219.
29. Delengocky T, Bui CM. Complete ophthalmoplegia with papillary involvement as an initial clinical presentation of herpes zoster ophthalmicus. J Am Osteopath Assoc. 2008;108(10): 615-621.
30. Wickremasinghe SS, Stawell R, Lim L, Pakrou N, Zamir E. Nonnecrotizing herpetic vasculitis. Ophthalmology. 2009;116(2):361.
31. Arda H, Mirza E, Gumus K, Oner A, Karakucuk S, Satrakaya E. Orbital apex syndrome in herpes zoster ophthalmicus. Case Rep Ophthalmol Med. 2012;2012:854503.
32. Oxman MN, Levin MJ, Johnson GR, et al; Shingle Prevention Study Group. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005;352(22): 2271-2284.
33. Harpaz R, Ortega-Sanchez IR, Seward JF; Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2008;57(RR-5):1-30; quiz CE2-CE4.
34. Schmader K, Gnann JW Jr, Watson CP. The epidemiological, clinical, and pathological rationale for the herpes zoster vaccine. J Infect Dis. 2008;197(suppl 2):S207-S215.
35. St Sauver JL, Grossardt BR, Yawn BP, et al. Data resource profile: the Rochester Epidemiology Project (REP) medical records-linkage system. Int J Epidemiol. 2012;41(6):1614-1624.
36. St Sauver JL, Grossardt BR, Leibson CL, Yawn BP, Melton LJ 3rd, Rocca WA. Generalizability of epidemiological findings and public health decisions: an illustration from the Rochester Epidemiology Project. Mayo Clin Proc. 2012;87(2): 151-160.
37. St Sauver JL, Grossardt BR, Yawn BP, Melton LJ 3rd, Rocca WA. Use of a medical records linkage system to enumerate a dynamic population over time: the Rochester Epidemiology Project. Am J Epidemiol. 2011;173(9):1059-1068.
38. Rocca WA, Yawn BP, St Sauver JL, Grossardt BR, Melton LJ Jr. History of the Rochester Epidemiology Project: half a century of medical records linkage in a US population. Mayo Clin Proc. 2012;87(12):1202-1213.
39. Melton LJ 3rd. History of the Rochester Epidemiology Project. Mayo Clin Proc. 1996;71(3):266-274.
40. Yawn BP, Yawn RA, Geier GR, Xia Z, Jacobsen SJ. The impact of requiring patient authorization for use of data in medical records research. J Fam Pract. 1998;47(5):361-365.
41. Yawn BP, Wollan P. Interrater reliability: completing the methods description in medical records review studies. Am J Epidemiol. 2005;161(10):974-977.
42. Welsby PD. Chickenpox, chickenpox vaccination, and shingles. Postgrad Med J. 2006;82(967):351-352.
43. Russell ML, Schopflocher DP, Svenson L, Virani SN. Secular trends in the epidemiology of shingles in Alberta. Epidemiol Infect. 2007;135(6):908-913.
44. Haargaard B, Lund-Andersen H, Milea D. Central nervous system involvement after herpes zoster ophthalmicus. Acta Ophthalmol. 2008;86(7):806-809.
45. Kido S, Sugita S, Horie S, et al. Association of varicella zoster virus load in the aqueous humor with clinical manifestations of anterior uveitis in herpes zoster ophthalmicus and zoster sine herpete. Br J Ophthalmol. 2008;92(4):505-508.
46. Matthews MS, Sorkin GC, Brant-Zawadzki M. Varicella zoster infection of the brainstem followed by Brown-Séquard syndrome. Neurology. 2009;72(21):1874.
47. Lin P, Yoon MK, Chiu CS. Herpes zoster keratouveitis and inflammatory ocular hypertension 8 years after varicella vaccination. Ocul Immunol Inflamm. 2009;17(1):33-35.
48. Najjar DM, Youssef OH, Flanagan JC. Palpebral subconjunctival hemorrhages in herpes zoster ophthalmicus. Ophthalmol Plast Reconstr Surg. 2008;24(2):162-164.
49. Dhingra S, Williams G, Pearson A. Severe, permanent orbital disease in herpes zoster ophthalmicus. Orbit. 2008; 27(4):325-327.
50. Wickremasinghe SS, Stawell R, Lim L, Pakrou N, Zamir E. Nonnecrotizing herpetic vasculitis. Ophthalmology. 2009;116(2): 361.
51. Pavan-Langston D, Dohlman CH. Boston keratoprosthesis treatment of herpes zoster neurotrophic keratopathy. Ophthalmology. 2008;115(2, suppl):S21-S23.
52. Sáenz-Francés F, Calvo-González C, Jiménez-Santos M, et al. Herpetic optic neuritis associated with herpetic keratitis. Eur J Ophthalmol. 2007;17(4):683-684.
53. Pion B, Salu P. Herpes zoster ophthalmicus complicated by complete ophthalmoplegia and signs of pilocarpine hypersensitivity. A case report and literature review. Bull Soc Belge Ophtalmol. 2007;303:23-26.
54. Im M, Kim BJ, Seo YJ, Park JK, Lee JH. Complete ophthalmoplegia after herpes zoster. Clin Exp Dermatol. 2007;32(2): 162-164.
55. Muthiah MN, Michaelides M, Child CS, Mitchell SM. Acute retinal necrosis: a national population-based study to assess the incidence, methods of diagnosis, treatment strategies and outcomes in the UK. Br J Ophthalmol. 2007;91(11):1452-1455.
56. Lau CH, Missotten T, Salzmann J, Lightman SL. Acute retinal necrosis features, management, and outcomes. Ophthalmology. 2007;114(4):756-762.
57. Cordero-Coma M, Anzaar F, Yilmaz T, Foster CS. Herpetic retinitis. Herpes. 2007;14(1):4-10.
58. Deitch SB, Gilden DH. Varicella zoster virus infection in HIVpositive and AIDS patients. In: Minagan A, Shapshak P, eds. Neuro-AIDS. Hauppauge, NY: Nova Science Publishers; 2006: 186-198.
59. Yawn BP, Wollan P, St Sauver J. Comparing shingles incidence and complication rates from medical record review and administrative database estimates: how close are they? Am J Epidemiol. 2011;174(9):1054-1061.
60. Tseng HF, Smith N, Harpaz R, Bialek SR, Sy LS, Jacobsen SJ. Herpes zoster vaccine in older adults and the risk of subsequent herpes zoster disease. JAMA. 2011;305(2):160-166.
61. Sy A, McLeod SD, Cohen EJ, et al. Practice patterns and opinions in the management of recurrent or chronic herpes zoster ophthalmicus. Cornea. 2012;31(7):786-790.
62. Lam FC, Law A, Wykes W. Herpes zoster ophthalmicus. BMJ. 2009;339:b2624.